ProShares' XRP Futures ETFs Postponed as Bloomberg Analyst Confirms Timeline Shift
ProShares has delayed the launch of its highly anticipated XRP futures ETFs, with no confirmed release date yet announced. Bloomberg ETF analyst James Seyffart clarified that earlier reports suggesting an April 30 debut were inaccurate.
Key Takeaways
- Launch Postponement: ProShares’ three proposed XRP futures ETFs (Short XRP, Ultra XRP, and UltraShort XRP) face an indefinite delay.
- Market Optimism: Positive sentiment persists for XRP ETF approval, fueled by CME Group’s planned XRP futures and regulatory developments.
- Price Performance: XRP trades at $2.27, showing modest gains but underperforming other layer-1 assets.
Details of the Delay
James Seyffart confirmed via Twitter:
"ProShares will not launch XRP ETFs on April 30th. While we expect a launch in the short-to-medium term, no specific date is set."
The delay follows CME Group’s announcement of XRP futures, a move seen as a precursor to broader ETF adoption. Analysts speculate that ProShares may await clearer regulatory signals, particularly after Ripple Labs’ ongoing SEC case concludes.
Market Context
XRP’s price remains volatile, currently up 9% over the past week but lagging behind competitors. Regulatory shifts—such as Paul Atkins’ SEC leadership—have bolstered hopes for eventual ETF approval.
👉 Explore how XRP futures could reshape crypto markets
FAQs
1. Why was ProShares’ XRP ETF launch delayed?
ProShares has not disclosed specifics, but analysts attribute it to regulatory uncertainty and timing with CME’s XRP futures rollout.
2. How does CME’s XRP futures announcement impact ETFs?
Futures products often precede spot ETFs, as they establish regulated price benchmarks and liquidity.
3. What’s next for XRP ETF prospects?
Approval likely hinges on Ripple’s legal resolution and SEC policy under new leadership.
👉 Stay updated on XRP ETF developments
Conclusion
While setbacks occur, the groundwork for XRP ETFs—through futures and regulatory progress—suggests eventual viability. Investors should monitor SEC rulings and CME’s futures launch for clearer signals.